After developing the world’s first integrative medicine for successfully treating Lymphedema and Lymphatic Filariasis, Kerala-based Institute of Applied Dermatology (IAD) is now further advancing molecular research in Filarial Lymphedema to develop advanced diagnostics and integrated therapeutic interventions for lymphatic filariasis.
IAD, a not-for-profit institution in Kasaragod, has forged a collaborative partnership with SRM University, Andhra Pradesh for undertaking the molecular research on Filarial Lymphedema. A Memorandum of Understanding (MoU) was recently signed between the two institutions in this regard.
Filarial Lymphedema, caused by the parasitic infection of lymphatic vessels, poses a significant health challenge, particularly in tropical regions. The partnership between IAD and SRM University is aimed at deciphering the molecular pathways driving cellular functions, disease progression, and physiological responses associated with Filarial Lymphedema.
“The research will leverage cutting-edge molecular techniques and incorporate insights from Ayurveda, the traditional Indian system of medicine, for developing advanced diagnostics and integrated therapeutic interventions for treating Lymphatic Filariasis,” said IAD founder-director Dr S R Narahari.
“Our partnership with SRM University opens new avenues for exploring holistic approaches to further tackle Filarial Lymphedema. By synergiing modern scientific methods with the ancient wisdom of Ayurveda, the research aims to develop targeted therapy development and precision medicine for biomarker discovery and mechanistic understanding for improved diagnosis, treatment, and management of the disease,” Dr Narahari added.
The IAD, which successfully developed an integrative medicine for lymphedema and lymphatic filariasis combining allopathy with yoga and Ayurveda, decided to go in for molecular research in filarial lymphedema for the development of advanced diagnostic tools and immunomodulatory therapies for offering advanced treatment for patients.
“Through the collaborative research, we are aiming to make new discoveries that could redefine the understanding and treatment of Filarial Lymphedema,” Dr Narahari added.
This article has been published in partnership with Institute of Applied Dermatology
Be First to Comment